Apligraf: Clinical Trials

1 trial of Apligraf, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Apligraf: new trials by email Literature Review of Apligraf trials Research Report on Apligraf

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Apligraf in Nonhealing Wounds of Subjects With Junctional or Dystrophic Epidermolysis Bullosa (EB)
Apligraf, Standard dressing regimen - Epidermolysis Bullosa, Junctional, Epidermolysis Bullosa Dystrophica
Phase 3TerminatedOrganogenesis12007-12-012010-06-29

Conditions studied

Epidermolysis Bullosa Dystrophica (1)  ·  Epidermolysis Bullosa, Junctional (1)

Sponsors

Organogenesis (1)

Countries

United States (1)

Top investigators

Damien Bates, MD, PhD, FRACS (Plast.) (1)  ·  Elizabeth Alvarez- Connelly, MD (1)